Skip to content

Immersive Virtual Reality-Based Sensory Stimulation for Delirium Prevention in Neurocritical Care Patients: A Randomized Controlled Trial

Effect of Sensory Stimulation Based on Immersive Virtual Reality Technology on Delirium Prevention in Neurological ICU Patients: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600125494
Enrollment
Unknown
Registered
2026-05-27
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nervous system diseases

Interventions

Control group:Routine standardized ABCDEF bundle intervention
Intervention group:Routine standardized ABCDEF bundle intervention combined with sensory-perceptual stimulation training based on immersive virtual reality (IVR) technology

Sponsors

Beijing Tiantan Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Postoperative patients with neurological diseases (including stroke, traumatic brain injury, brain tumors, etc., which meet the ICD-11 diagnostic criteria for neurological disorders and have been definitively confirmed by imaging modalities such as CT or MRI) ; 2. Age >= 18 years; 3. Alert mental status, with a Glasgow Coma Scale (GCS) score >= 13; 4. Richmond Agitation-Sedation Scale (RASS) score between -1 and 1; 5. Muscle strength grade >= IV in at least one upper limb; 6. Expected length of ICU stay >= 24 hours; 7. Provision of informed consent and willingness to participate in the study.

Exclusion criteria

Exclusion criteria: 1. Patients with severe visual, hearing, or communication impairments that preclude cooperation with training; 2. Patients with contraindications to physical activity (e.g., restricted head or neck movement, unstable fractures) or other conditions that render the equipment unusable; 3. Patients who are unable to comprehend VR video or game instructions or to follow simple commands; 4. Patients with existing mental confusion or delirium; 5. Patients with suspected or confirmed drug or alcohol abuse, intoxication, overdose, or withdrawal; 6. Patients requiring or currently undergoing invasive mechanical ventilation; 7. Pregnant women.

Design outcomes

Primary

MeasureTime frame
Incidence of delirium during ICU treatment;

Secondary

MeasureTime frame
Incidence of subsyndromal delirium during ICU treatment;Anxiety and depression levels during ICU treatment;Pain levels during ICU treatment;

Countries

China

Contacts

Public ContactWeixin Cai

Beijing Tiantan Hospital, Capital Medical University

ttyyhlb@163.com+86 10 5997 8336

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026